A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies. [electronic resource]
Producer: 20080611Description: 109-19 p. digitalISSN:- 1365-2141
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antibody-Dependent Cell Cytotoxicity -- immunology
- Erythrocytes -- immunology
- Hemolysis -- genetics
- Humans
- Immunoglobulin G -- immunology
- Isoantibodies -- immunology
- Male
- Middle Aged
- Polymorphism, Genetic
- Receptors, IgG -- genetics
- Rho(D) Immune Globulin -- immunology
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.